KBKaryn L. Butler

Karyn L. Butler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karyn L. Butler has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing Advanced Practitioner Charge Capture in High-Acuity Surgical Intensive Care Units

    by Karyn L. Butler, Rebecca Calabrese, Manish Tandon, Orlando C. Kirton

    Between 2000 and 2005, the number of critical care beds in the United States increased by 6.5%, accounting for greater than 13% of hospital costs, 4% of national health expenditures, and 0.6% of the gross domestic product.1 As capacity and health care costs increase, hospitals must identify methods to enhance revenue generation, ensure appropriate and adequate clinical coverage, and maintain compliance with reimbursement guidelines through adherence to proper coding of evaluation and management (E&M) services. These codes determine reimbursement according to the complexity of the patient evaluation and the type of service delivered. For critical care providers, these services are based on time and typically reflect the aggregate time that a provider cares for a critically ill patient during a workday.


  • Open Access

    STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough?

    by Michael D. Goodman, Sheryl E. Koch, Muhammad R. Afzal, Karyn L. Butler

    The role of other STAT subtypes in conferring ischemic tolerance is unclear. We hypothesized that in STAT-3 deletion alternative STAT subtypes would protect myocardial function against ischemia-reperfusion injury. Wild-type (WT) male C57BL/6 mice or mice with cardiomyocyte STAT-3 knockout (KO) underwent baseline echocardiography. Langendorff-perfused hearts underwent ischemic preconditioning (IPC) or no IPC before ischemia-reperfusion. Following ex vivo perfusion, hearts were analyzed for STAT-5 and -6 phosphorylation by Western blot analysis of nuclear fractions. Echocardiography and postequilibration cardiac performance revealed no differences in cardiac function between WT and KO hearts. Phosphorylated STAT-5 and -6 expression was similar in WT and KO hearts before perfusion. Contractile function in WT and KO hearts was significantly impaired following ischemia-reperfusion in the absence of IPC. In WT hearts, IPC significantly improved the recovery of the maximum first derivative of developed pressure (+dP/dtmax) compared with that in hearts without IPC. IPC more effectively improved end-reperfusion dP/dtmax in WT hearts compared with KO hearts. Preconditioned and nonpreconditioned KO hearts exhibited increased phosphorylated STAT-5 and -6 expression compared with WT hearts. The increased subtype activation did not improve the efficacy of IPC in KO hearts. In conclusion, baseline cardiac performance is preserved in hearts with cardiac-restricted STAT-3 deletion. STAT-3 deletion attenuates preconditioning and is not associated with a compensatory upregulation of STAT-5 and -6 subtypes. The activation of STAT-5 and -6 in KO hearts following ischemic challenge does not provide functional compensation for the loss of STAT-3. JAK-STAT signaling via STAT-3 is essential for effective IPC.